A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive suite of antibody discovery platforms.